Influenza H3N2 variant viruses with pandemic potential: preventing catastrophe in remote and isolated Canadian communities
- PMID: 23628518
- DOI: 10.1016/j.ypmed.2013.04.011
Influenza H3N2 variant viruses with pandemic potential: preventing catastrophe in remote and isolated Canadian communities
Abstract
Objective: To evaluate the impact of age-specific cross-reactive antibody protection levels on the outcomes of a pandemic outbreak of new variants of H3N2 influenza A viruses (H3N2v).
Methods: We calibrated a previously validated agent-based model of human-to-human transmission of influenza viruses to project the outcomes of various protection levels in a remote and isolated Canadian community, when demographics are drawn from the Statistics Canada census data. We then compared the outcomes with a scenario in which demographic variables were shifted to resemble an urban structure. This comparative evaluation was conducted using in-silico computer simulations, where the epidemiological data were drawn from relevant estimates in published literature.
Results: Simulations, using estimates of transmissibility for the 2009 H1N1 pandemic strain in the study population, show that the epidemic size is primarily affected by the cross-reactive protection levels of young children. A lower number of secondary infections at the early stages of an outbreak does not necessarily correspond to a lower epidemic size.
Conclusions: Demographic variables could play a significant role in determining the outcomes of an outbreak. The findings strongly suggest that, when an H3N2v-specific vaccine becomes available, children below the age of 17 should be prioritized for vaccination. This prioritization is essential in population settings with a low average age, including aboriginal communities in northern latitudes.
Keywords: Agent-based modeling; Cross-reactive antibody protection; Pandemic influenza; Remote and isolated communities; Vaccination.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States.MMWR Morb Mortal Wkly Rep. 2012 Apr 13;61(14):237-41. MMWR Morb Mortal Wkly Rep. 2012. PMID: 22495226
-
Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).J Infect Dis. 2012 Dec 15;206(12):1852-61. doi: 10.1093/infdis/jis500. Epub 2012 Aug 7. J Infect Dis. 2012. PMID: 22872731
-
Genetic drift influenza A(H3N2) virus hemagglutinin (HA) variants originated during the last pandemic turn out to be predominant in the 2011-2012 season in Northern Italy.Infect Genet Evol. 2013 Jan;13:252-60. doi: 10.1016/j.meegid.2012.10.019. Epub 2012 Nov 19. Infect Genet Evol. 2013. PMID: 23174527
-
Assessing the effectiveness and feasibility of implementing mitigation measures for an influenza pandemic in remote and isolated First Nations communities: a qualitative community-based participatory research approach.Rural Remote Health. 2013 Oct-Dec;13(4):2566. Epub 2013 Nov 21. Rural Remote Health. 2013. PMID: 24261860
-
Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.Clin Microbiol Infect. 2012 Feb;18(2):177-83. doi: 10.1111/j.1469-0691.2011.03545.x. Epub 2011 Jun 2. Clin Microbiol Infect. 2012. PMID: 21635661
Cited by
-
Detection of influenza A virus in aerosols of vaccinated and non-vaccinated pigs in a warm environment.PLoS One. 2018 May 21;13(5):e0197600. doi: 10.1371/journal.pone.0197600. eCollection 2018. PLoS One. 2018. PMID: 29782527 Free PMC article.
-
A Systematic Literature Review of Agents Applied in Healthcare.J Med Syst. 2016 Feb;40(2):43. doi: 10.1007/s10916-015-0376-2. Epub 2015 Nov 21. J Med Syst. 2016. PMID: 26590981 Review.
-
Impact of viral drift on vaccination dynamics and patterns of seasonal influenza.BMC Infect Dis. 2013 Dec 13;13:589. doi: 10.1186/1471-2334-13-589. BMC Infect Dis. 2013. PMID: 24330575 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

